ATE125155T1 - Niedrigdosierte getrocknete pharmazeutische präparate. - Google Patents

Niedrigdosierte getrocknete pharmazeutische präparate.

Info

Publication number
ATE125155T1
ATE125155T1 AT92103963T AT92103963T ATE125155T1 AT E125155 T1 ATE125155 T1 AT E125155T1 AT 92103963 T AT92103963 T AT 92103963T AT 92103963 T AT92103963 T AT 92103963T AT E125155 T1 ATE125155 T1 AT E125155T1
Authority
AT
Austria
Prior art keywords
disclosed
weight
agent
pharmaceutical preparations
tablet
Prior art date
Application number
AT92103963T
Other languages
English (en)
Inventor
Haan Pieter De
Marcus Johannes Deurloo
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8207548&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE125155(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE125155T1 publication Critical patent/ATE125155T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
AT92103963T 1991-03-12 1992-03-09 Niedrigdosierte getrocknete pharmazeutische präparate. ATE125155T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91200524 1991-03-12

Publications (1)

Publication Number Publication Date
ATE125155T1 true ATE125155T1 (de) 1995-08-15

Family

ID=8207548

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92103963T ATE125155T1 (de) 1991-03-12 1992-03-09 Niedrigdosierte getrocknete pharmazeutische präparate.

Country Status (18)

Country Link
US (1) US5382434A (de)
EP (1) EP0503521B2 (de)
JP (1) JP3474210B2 (de)
KR (1) KR100198017B1 (de)
CN (1) CN1039086C (de)
AT (1) ATE125155T1 (de)
AU (1) AU651869B2 (de)
CA (1) CA2062428C (de)
DE (1) DE69203488T3 (de)
DK (1) DK0503521T4 (de)
ES (1) ES2077897T5 (de)
FI (1) FI100770B (de)
GR (1) GR3017737T3 (de)
HK (1) HK1002018A1 (de)
IE (1) IE67345B1 (de)
NO (1) NO305055B1 (de)
NZ (1) NZ241915A (de)
ZA (1) ZA921659B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA924617B (en) 1991-03-25 1994-05-27 Boart International S A Pty Lt A percussion drill bit
US5976570A (en) * 1993-12-21 1999-11-02 Applied Analytical Industries, Inc. Method for preparing low dose pharmaceutical products
ZA939566B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for dry blend compression od medicaments.
US5928668A (en) * 1993-12-21 1999-07-27 Applied Analytical Industries, Inc. Method for dry blend compression of medicaments
ZA939565B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.
ZA949929B (en) * 1993-12-23 1995-08-23 Akzo Nobel Nv Sugar-coated pharmaceutical dosage unit.
US6077533A (en) * 1994-05-25 2000-06-20 Purdue Pharma L.P. Powder-layered oral dosage forms
ATE236639T1 (de) * 1994-09-22 2003-04-15 Akzo Nobel Nv Verfahren zur herstellung von dosierungsformen durch feuchtgranulierung
IL115445A (en) * 1994-10-17 1999-08-17 Akzo Nobel Nv Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation
EP0820237A4 (de) * 1995-01-25 1999-01-20 Wrigley W M Jun Co Verbesserte einstaubmischung und verfahren zur herstellung von kaugummi mit ihrer hilfe
TR199701659T1 (xx) * 1995-06-22 1998-03-21 Akzo Nobel N.V. S�k��t�r�lm��, kuru gran�l haline getirilmi� desogestrel tabletleri.
DE19652196A1 (de) 1996-12-16 1998-06-18 Jenapharm Gmbh Homogene steroidhaltige Präformulierungen zur Herstellung niedrigdosierter fester und halbfester pharmazeutischer Zubereitungen
AU2669700A (en) * 1999-02-24 2000-09-14 Akzo Nobel N.V. Pharmaceutical compositions containing a crystalline form of the progestagen-(17alpha)-17-hydroxy-11-methylene-19-nor-pregna- 4,15-dien-20-yn-3-one (org 30659) and lactose
KR20010006835A (ko) * 1999-03-25 2001-01-26 김선진 경구용 속붕해정
DE19917347A1 (de) 1999-04-16 2000-11-09 Gsf Forschungszentrum Umwelt Verfahren und Vorrichtung zum trockenen Anbringen von Substanzen an inhalierbare pulverförmige Trägerstoffe
ITMI991582A1 (it) * 1999-07-16 2001-01-16 Chiesi Farma Spa Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
FR2801218B1 (fr) * 1999-11-23 2001-12-28 Hoechst Marion Roussel Inc Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
AU2583401A (en) * 1999-12-20 2001-07-03 Cocensys, Inc. Process for producing nanometer particles by fluid bed spray-drying
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
JP5033297B2 (ja) 2000-07-20 2012-09-26 カムピナ・ベスローテン・フェンノートシャップ 結晶性の錠剤化用添加剤の製造方法、それにより得られる添加剤、およびその使用
DE60139087D1 (de) * 2000-12-14 2009-08-06 Ortho Mcneil Janssen Pharm Verfahren zu Herstellung von Zubereitungen enthaltend einen Steroidhormon und ein Stabilisierungsmittel in nicht-kristallinen Form
US20040071772A1 (en) * 2001-03-06 2004-04-15 Shoichi Narita Preparations quickly disintegrating in oral cavity
EP1369131A1 (de) * 2001-03-06 2003-12-10 Kyowa Hakko Kogyo Co., Ltd. Verwendung eines sprühgetrockneten pulvers, das zuckeralkohol enthält
GEP20053654B (en) * 2001-05-01 2005-11-10 Pfizer Prod Inc Method For Manufacturing Low Dose Pharmaceutical Composition Having Uniform Drug Distribution
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
US6962908B2 (en) 2001-12-21 2005-11-08 Warner Chilcott Company Inc. Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
US7833545B2 (en) 2003-04-29 2010-11-16 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
US7444197B2 (en) 2004-05-06 2008-10-28 Smp Logic Systems Llc Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes
US7799273B2 (en) 2004-05-06 2010-09-21 Smp Logic Systems Llc Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes
TWI356036B (en) * 2004-06-09 2012-01-11 Smithkline Beecham Corp Apparatus and method for pharmaceutical production
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
EP2178540A4 (de) * 2007-08-01 2012-01-04 Stellan Hjerten Pharmazeutische zusammensetzung zur adsorption auf der zelloberfläche von pathogenen mikroben
US8288342B2 (en) * 2008-10-10 2012-10-16 Teva Women's Health, Inc. Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate
EP2405905B1 (de) * 2009-03-09 2016-06-29 SPI Pharma, INC. Hoch verdichtungsfähige und beständige direktkompressionshilfsstoffe und hilfsstoffsysteme
HUP0900698A2 (en) 2009-11-06 2011-06-28 Richter Gedeon Nyrt Pharmaceutical compositions of enhanced stability containing drospirenone and ethynyl estradiol and process for their preparation
EP2354150A1 (de) * 2010-02-09 2011-08-10 Laboratoire Theramex Verfahren zur Herstellung von Gestoden
WO2012120365A1 (en) 2011-03-07 2012-09-13 Aurobindo Pharma Limited Stable pharmaceutical composition comprising ethinyl estradiol
CN102416003A (zh) * 2011-12-08 2012-04-18 南京优科生物医药有限公司 一种制备恩替卡韦片剂的方法
HUE050050T2 (hu) * 2013-03-04 2020-11-30 Besins Healthcare Lu Sarl Hordozórészecskékhez kötõdõ hatóanyag nanorészecskéket tartalmazó száraz gyógyászati kompozíciók

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626063A (en) * 1959-08-11 1971-12-07 Upjohn Co Therapeutic compositions comprising 6-fluoro-16-methyl prednisolone, the 21 acylates and salts thereof
US3344030A (en) * 1964-06-15 1967-09-26 American Home Prod Reinforced directly compressed nongranulated pharmaceutical crystalline lactose tables
US3423507A (en) * 1966-02-25 1969-01-21 Schering Corp Method of treating benign prostratic hypertrophy
US3568828A (en) * 1967-03-01 1971-03-09 Squibb & Sons Inc Modified sequential oral contraceptive
US3671633A (en) * 1971-05-10 1972-06-20 American Cyanamid Co Process for tabletting acetazolamide
US3802914A (en) * 1972-04-10 1974-04-09 Kraftco Corp Method of treating lactose
SE378109B (de) * 1972-05-19 1975-08-18 Bofors Ab
DE2365103C3 (de) * 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
DE2524902C2 (de) * 1975-06-02 1984-10-25 Schering AG, 1000 Berlin und 4709 Bergkamen Vorrichtung zur Inhalation von Arzneimitteln
US4143136A (en) * 1976-11-20 1979-03-06 Akzona Incorporated Method of contraception
DE2716323C2 (de) * 1977-04-07 1986-03-13 Schering AG, 1000 Berlin und 4709 Bergkamen Vorrichtung zur Inhalation von Arzneimitteln
NL8001593A (nl) * 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
US4916163A (en) * 1985-06-04 1990-04-10 The Upjohn Company Spray-dried lactose formulation of micronized glyburide

Also Published As

Publication number Publication date
IE920634A1 (en) 1992-09-23
ZA921659B (en) 1992-11-25
AU651869B2 (en) 1994-08-04
EP0503521B2 (de) 2005-11-09
FI921023A0 (fi) 1992-03-09
US5382434A (en) 1995-01-17
HK1002018A1 (en) 1998-07-24
JP3474210B2 (ja) 2003-12-08
AU1211992A (en) 1992-09-17
IE67345B1 (en) 1996-03-20
NO305055B1 (no) 1999-03-29
ES2077897T5 (es) 2006-06-16
EP0503521A1 (de) 1992-09-16
FI921023A (fi) 1992-09-13
FI100770B (fi) 1998-02-27
CA2062428A1 (en) 1992-09-13
DK0503521T4 (da) 2005-12-05
CN1064810A (zh) 1992-09-30
EP0503521B1 (de) 1995-07-19
NZ241915A (en) 1994-04-27
CA2062428C (en) 2002-07-30
NO920958D0 (no) 1992-03-11
DE69203488T3 (de) 2006-07-06
NO920958L (no) 1992-09-14
KR100198017B1 (ko) 1999-06-15
DK0503521T3 (da) 1995-11-27
CN1039086C (zh) 1998-07-15
DE69203488T2 (de) 1996-01-11
ES2077897T3 (es) 1995-12-01
JPH0578251A (ja) 1993-03-30
DE69203488D1 (de) 1995-08-24
KR920017656A (ko) 1992-10-21
GR3017737T3 (en) 1996-01-31

Similar Documents

Publication Publication Date Title
ATE125155T1 (de) Niedrigdosierte getrocknete pharmazeutische präparate.
IE891414L (en) Pharmaceutical compositions
KR890001526A (ko) 경구용 서방성 아세트 아미노펜 제형 및 이의 제조방법
RU93036959A (ru) Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства
NO922807D0 (no) Farmasoeytiske dideoksypurinnukleosid-preparater til oraltbruk
KR880004805A (ko) 분무건조된 아세트아미노펜
ES2076358T3 (es) Granulados con elevado contenido de ibuprofeno.
EP0391374A3 (de) Verfahren zur Herstellung von Bromocriptin enthaltenden Arzneimittelzubereitungen mit hoher Stabilität und in Beziehung zueinander stehende Produkte
NZ236631A (en) Process for the preparation of a spray dried powdered pharmaceutical formulation of naproxen
DK0483320T3 (da) Farmaceutiske sammensætninger med forlænget frigivelse til peroral indgivelse og fremgangsmåde til fremstilling deraf
DE68907091T2 (de) Scleroglucan und Wirkstoff enthaltende pharmazeutische Tabletten und Kapselgranulate.
Fateeva Pharmacokinetics of amphoglucamine in an experiment
NO176948C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat i enhetsdoseform omfattende finmalt colestipol-hydroklorid
WO2001010415B1 (en) A binder for pharmaceutical compositions
JPS57176907A (en) Readily absorbable solid pharmaceutical composition of as-56c
JPS5462327A (en) Remedy for dna virus infectious disease
JPS57112327A (en) Antidiabetic agent comprising 2,3-dihydroxypropyl ester of n-(7-chloro-4-quinolyl)anthranillic acid
CA2176461A1 (en) Method for preparing low dose pharmaceutical products
JPS57112329A (en) Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification

Ref document number: 0503521

Country of ref document: EP